Condition: Non-Alcoholic Fatty Liver Disease · Non-Alcoholic Steatohepatitis · Alcohol-related Liver Disease · Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
The aim is to determine the metabolic factors, host immune factors, and medical imaging data associated with the development of HepatoCellular Carcinoma (HCC) in patients with alcohol-related liver disease or dysmetabolic steatosis/Non-Alcoholic SteatoHepatitis. The investigators will include patients with and without cirrhosis in order to identify early molecular mechanisms involved in the development of HCC especially in non-cirrhotic patients.
This description comes directly from the study's public registry record.
Rodolphe Anty, MD, PhD · 0033492035943 · anty.r@chu-nice.fr
Always discuss trial participation with your own doctor first.
| Batiment Archimed 151, route de Saint Antoine de Ginestière | Nice, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05623150